user

Phase II Trial of Weekly Nab-Paclitaxel for Previously Treated Advanced Non-Small Cell Lung Cancer: KTOSG Trial 1301

被引：0
|
作者：
Sakata, Shinya [1 ]
Saeki, Sho [1 ]
Okamoto, Isamu [2 ]
Otsubo, Kohei [2 ]
Komiya, Kazutoshi [3 ]
Morinaga, Ryotaro [4 ]
Yoneshima, Yasuto [2 ]
Koga, Yuichiro [2 ]
Enokizu, Aimi [2 ]
Kishi, Hiroto [5 ]
Hirosako, Susumu [1 ]
Yamaguchi, Emi [1 ]
Aragane, Naoko [3 ]
Fujii, Shinji [6 ]
Harada, Taishi [2 ]
Iwama, Eiji [2 ]
Nakanishi, Yoichi [2 ]
Kohrogi, Hirotsugu [1 ]
机构：
[1] Kumamoto Univ Hosp, Dept Resp Med, Kumamoto, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Res Inst Dis Chest, Fukuoka, Japan
[3] Saga Univ, Saga, Japan
[4] Oita Prefectural Hosp, Dept Resp Med & Oncol, Oita, Japan
[5] Kumamoto City Hosp, Dept Resp Med, Kumamoto, Japan
[6] Kumamoto Reg Med Ctr, Div Resp Dis, Kumamoto, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
non-small cell lung cancer; objective response rate; nab-paclitaxel; phase II trial;
D O I：
10.1016/j.jtho.2016.11.1266
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.03a-056
引用
收藏
页码：S923 / S923
页数：1
相关论文
共 50 条
  • [1] Phase II trial of weekly nab-paclitaxel for previously treated advanced non-small cell lung cancer: Kumamoto thoracic oncology study group (KTOSG) trial 1301
    Sakata, Shinya
    Saeki, Sho
    Okamoto, Isamu
    Otsubo, Kohei
    Komiya, Kazutoshi
    Morinaga, Ryotaro
    Yoneshima, Yasuto
    Koga, Yuichiro
    Enokizu, Aimi
    Kishi, Hiroto
    Hirosako, Susumu
    Yamaguchi, Emi
    Aragane, Naoko
    Fujii, Shinji
    Harada, Taishi
    Iwama, Eiji
    Semba, Hiroshi
    Nakanishi, Yoichi
    Kohrogi, Hirotsugu
    LUNG CANCER, 2016, 99 : 41 - 45
  • [2] Phase II Study of the Modified Weekly Nab-paclitaxel Regimen in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer
    Yoshimura, Naruo
    Sawa, Kenji
    Nakai, Toshiyuki
    Matsumoto, Yoshiya
    Mitsuoka, Shigeki
    Kimura, Tatsuo
    Asai, Kazuhisa
    Yana, Takashi
    Kawaguchi, Tomoya
    Hirata, Kazuto
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (12): : 613 - 618
  • [3] The NICE Salvage Study: A Phase II Trial of Weekly Nab-Paclitaxel in the Salvage Setting for Advanced Non-Small Cell Lung Cancer
    Niwa, Takashi
    Yoshioka, Hiroshige
    Hata, Akito
    Azuma, Koichi
    Tajima, Manabu
    Morita, Mitsunori
    Kogure, Yoshihito
    Akamatsu, Hiroaki
    Ishida, Tadashi
    Katakami, Nobuyuki
    Hoshino, Tomoaki
    Takenoyama, Mitsuhiro
    Takahashi, Kazuhisa
    Kaneda, Hiroyasu
    Tomioka, Hiromi
    Saka, Hideo
    Ando, Masahiko
    Yamamoto, Nobuyuki
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1078 - S1079
  • [4] Phase I/II Trial of Biweekly Nab-Paclitaxel in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer: NJLCG1402
    Tanaka, H.
    Miyauchi, E.
    Nakamura, A.
    Harada, T.
    Nakagawa, T.
    Morita, M.
    Jingu, D.
    Tomoya, K.
    Gamou, S.
    Saito, R.
    Inoue, A.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S916 - S916
  • [5] A phase II trial of nab-paclitaxel and gemcitabine in patients with non-small cell lung cancer previously treated with platinum based chemotherapy
    Hatakeyama, Y.
    Tachihara, M.
    Kiriu, T.
    Hata, A.
    Nagano, T.
    Yamamoto, M.
    Kobayashi, K.
    Ohnishi, H.
    Katakami, N.
    Nishimura, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S102 - S102
  • [6] A Phase II Trial of Weekly Nab-Paclitaxel in the Salvage Setting for Advanced Non-Small Cell Lung Cancer: Results of NICE Salvage Study
    Kogure, Y.
    Niwa, T.
    Yoshioka, H.
    Saka, H.
    Hata, A.
    Katakami, N.
    Ozawa, Y.
    Matsuo, N.
    Hoshino, T.
    Wakuda, K.
    Kenmotsu, H.
    Takahashi, T.
    Nosaki, K.
    Takenoyama, M.
    Tajima, M.
    Takahashi, K.
    Ando, M.
    Yamamoto, N.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S355 - S356
  • [7] A single-arm phase II trial of weekly nanoparticle albumin-bound paclitaxel (nab-paclitaxel) monotherapy after standard of chemotherapy for previously treated advanced non-small cell lung cancer
    Kato, Yasuhiro
    Okuma, Yusuke
    Watanabe, Kageaki
    Yomota, Makiko
    Kawai, Shoko
    Hosomi, Yukio
    Okamura, Tatsuru
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (02) : 351 - 358
  • [8] A single-arm phase II trial of weekly nanoparticle albumin-bound paclitaxel (nab-paclitaxel) monotherapy after standard of chemotherapy for previously treated advanced non-small cell lung cancer
    Yasuhiro Kato
    Yusuke Okuma
    Kageaki Watanabe
    Makiko Yomota
    Shoko Kawai
    Yukio Hosomi
    Tatsuru Okamura
    Cancer Chemotherapy and Pharmacology, 2019, 84 : 351 - 358
  • [9] A Phase I Trial of Weekly Nab-paclitaxel Plus Carboplatin With Thoracic Radiotherapy for Non-small Cell Lung Cancer
    Kubota, Tetsuya
    Sakai, Mizu
    Anabuki, Kazuki
    Takamatsu, Kazufumi
    Mukaida, Kenichi
    Kobayashi, Kana
    Yamagami, Takuji
    Yokoyama, Akihito
    IN VIVO, 2024, 38 (01): : 259 - 263
  • [10] Phase II trial of weekly paclitaxel in previously untreated advanced non-small-cell lung cancer
    Yasuda, K
    Igishi, T
    Kawasaki, Y
    Yamamoto, M
    Kato, K
    Matsumoto, S
    Kotani, M
    Sako, T
    Shigeoka, Y
    Sugitani, A
    Histuda, Y
    Shimizu, E
    ONCOLOGY, 2003, 65 (03) : 224 - 228
12345